Ferrous iron binding to epinephrine promotes the oxidation of iron and impedes activation of adrenergic receptors
- PMID: 31911148
- DOI: 10.1016/j.freeradbiomed.2020.01.001
Ferrous iron binding to epinephrine promotes the oxidation of iron and impedes activation of adrenergic receptors
Abstract
Upon release in response to stress, epinephrine (Epi) may interact with labile iron pool in human plasma with potentially important (patho)physiological consequences. We have shown that Epi and Fe3+ build stable 1:1 high-spin bidentate complex at physiological pH, and that Epi does not undergo degradation in the presence of iron. However, the interactions of Epi with the more soluble Fe2+, and the impact of iron on biological activity of Epi are still not known. Herein we showed that Epi and Fe2+ build colorless complex which is stable under anaerobic conditions. In the presence of O2, Epi promoted the oxidation of Fe2+ and the formation of Epi-Fe3+ complex. Cyclic voltammetry showed that mid-point potential of Epi-Fe2+ complex is very low (-582 mV vs. standard hydrogen electrode), which explains catalyzed oxidation of Fe2+. Next, we examined the impact of iron binding on biological performance of Epi using patch clamping in cell culture with constitutive expression of adrenergic receptors. Epi alone evoked an increase of outward currents, whereas Epi in the complex with Fe3+ did not. This implies that the binding of Epi to adrenergic receptors and their activation is prevented by the formation of complex with iron. Pro-oxidative activity of Epi-Fe2+ complex may represent a link between chronic stress and cardiovascular problems. On the other hand, labile iron could serve as a modulator of biological activity of ligands. Such interactions may be important in human pathologies that are related to iron overload or deficiency.
Keywords: Adrenaline; Adrenergic receptor; Labile iron pool; Ligand; Oxidative stress; Reduction potential.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Coordinate and redox interactions of epinephrine with ferric and ferrous iron at physiological pH.Sci Rep. 2018 Feb 23;8(1):3530. doi: 10.1038/s41598-018-21940-7. Sci Rep. 2018. PMID: 29476145 Free PMC article.
-
Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity.Dalton Trans. 2007 Aug 14;(30):3232-44. doi: 10.1039/b704102k. Epub 2007 Jun 8. Dalton Trans. 2007. PMID: 17893768
-
Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.Biochim Biophys Acta. 2003 Mar 17;1620(1-3):15-24. doi: 10.1016/s0304-4165(02)00502-0. Biochim Biophys Acta. 2003. PMID: 12595068
-
Redox Sensing by Fe2+ in Bacterial Fur Family Metalloregulators.Antioxid Redox Signal. 2018 Dec 20;29(18):1858-1871. doi: 10.1089/ars.2017.7359. Epub 2017 Oct 31. Antioxid Redox Signal. 2018. PMID: 28938859 Free PMC article. Review.
-
Hemoglobin and Myoglobin as Reducing Agents in Biological Systems. Redox Reactions of Globins with Copper and Iron Salts and Complexes.Biochemistry (Mosc). 2016 Dec;81(13):1735-1753. doi: 10.1134/S0006297916130101. Biochemistry (Mosc). 2016. PMID: 28260494 Review.
Cited by
-
Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2.Egypt Heart J. 2024 Feb 20;76(1):22. doi: 10.1186/s43044-024-00455-9. Egypt Heart J. 2024. PMID: 38376738 Free PMC article.
-
Epinephrine as a Therapeutic Agent for Hyperferritinemia in Diabetes Mellitus and Hypertension.Am J Case Rep. 2025 Apr 20;26:e947289. doi: 10.12659/AJCR.947289. Am J Case Rep. 2025. PMID: 40253583 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical